ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.310
-0.020 (-0.60%)
At close: Sep 12, 2025, 4:00 PM EDT
3.370
+0.060 (1.81%)
After-hours: Sep 12, 2025, 7:25 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $372.37 million as of September 12, 2025. Its market cap has increased by 25.91% in one year.
Market Cap
372.37M
Enterprise Value
558.58M
1-Year Change
25.91%
Ranking
Category
Stock Price
$3.31
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $372.37M, a decrease of -81.77%. That is a compound annual growth rate of -27.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 372.37M | 93.53% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |